ScinoPharm Taiwan

ScinoPharm Taiwan is a leading global contract development and manufacturing organization (CDMO) specializing in high-quality active pharmaceutical ingredients (APIs). The company provides a comprehensive suite of services ranging from process research and development to commercial-scale production for both innovator and generic pharmaceutical firms. ScinoPharm is particularly renowned for its expertise in handling highly potent compounds, including cytotoxic oncology agents and complex small molecules. With manufacturing facilities in Taiwan and China, the company adheres to stringent international regulatory standards, holding certifications from the FDA, EMA, and PMDA. Their product portfolio includes a wide array of APIs for therapeutic areas such as oncology, central nervous system disorders, and cardiovascular diseases. By offering integrated solutions from clinical development to market launch, ScinoPharm serves as a critical partner in the global pharmaceutical supply chain.